In a prospective multi-ethnic cohort, patients with HFpEF had a lower adjusted risk of death compared to those with HFrEF, though NT-proBNP was similarly predictive of mortality across all phenotypes.
No takes yet. Share an insight, caveat, or question.
HFpEF was associated with lower mortality than HFrEF after adjustment; leaves open phenotype-specific risk stratification in prospective studies.
Lam et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: